HOME>News & Media
Innovation today, healthier tomorrows

 

Sunovion Pharmaceuticals Inc. is a fully integrated, research-based specialty pharmaceutical company dedicated to treating and preventing human disease by discovering, developing and commercializing innovative pharmaceutical products that are directed toward serving large and growing markets and unmet medical needs.
More >>

2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

 Date  Title
12/08/10 Latuda® (lurasidone HCl) Significantly Improves Symptoms of Schizophrenia in Fifth Positive Placebo-Controlled Study
12/04/10 New STEDESA™ Clinical Data Presented at American Epilepsy Society Annual Meeting
10/28/10 FDA approves once-daily LATUDA® (lurasidone HCl) for the treatment of patients with schizophrenia
10/12/10 Sunovion Pharmaceuticals Inc. Announces Company Name Change